Management of Treatment-Related Adverse Events Symposium

Systemic anticancer therapies (cytotoxic chemotherapies, targeted therapies, immunotherapies) have resulted in remarkable improvements in patient survival. Despite this remarkable success, the majority of patients will develop toxicities of various organ systems, which may impact overall health and activities of daily living, resulting in inconsistent antineoplastic therapy, all of which may affect clinical outcome. Therefore, prevention and management of untoward events is critical for the maintenance of quality of life and the optimization of anticancer therapies.

2020 Symposium Highlights

• Therapy-related adverse events will affect the majority of cancer patients, resulting in increased cost, inconsistent dosing, and decreased quality of life.
• With increased survival and patients living longer on therapy, adverse events affecting quality of life and clinical outcome command attention.
• Lectures focused on immune-related adverse events will describe the clinical presentation, diagnosis, and management strategies for the oncology healthcare provider.
• Up-to-date information will be presented on adverse event mechanisms and management from specialists in the most commonly affected organ systems.
• Practical strategies to identify patients at high risk will be highlighted, with strategies to direct patients towards the most efficient therapies based on healthcare providers.
• New strategies to monitor and manage symptoms of patients on active anticancer treatment will be discussed including patient-reported outcomes and teleoncology visits.

The target audience for this symposium includes MDs, PAs, NPs, RNs, Pharmacists, and other healthcare professionals treating cancer patients and their associated symptoms.

This course is endorsed by the Multinational Association of Supportive Care in Cancer.

1. Recognize the clinical presentation and impact on quality of life of treatment-related adverse events
2. Understand mechanisms to identify and triage patients at high risk for the development of toxicities
3. Discuss procedures and clinical strategies to prevent and treat adverse events in patients with cancer

Registration through the website is now closed. If you would still like to register, please email [email protected] before 9 am on 10/23.

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

By registering for the live virtual course, you will be able to view presentations, hear live audio, and interact online. All sessions presented live on October 23-24, 2020 will be recorded and made available to attendees for viewing after the course. CME and ABIM MOC credit will be offered for this course and a certificate will be available after a post-course evaluation is complete. This live virtual course will be delivered using Zoom. We encourage all attendees to download the Zoom app prior to the start of the course (zoom.us/download). Additional access details will be emailed to all attendees before the course. 

Registration Discounts/Promotions

• MSK CME offers a discounted rate for MSK Alumni, MSK Cancer Alliance and Cancer Care Partners. If you are a member of one of these groups, please contact [email protected] for more information.
• MSK employee registration is complimentary. However, you must complete course registration in order to attend this course. If you are registered for this course and are unable to attend, please email [email protected].

Please note that after your payment has been processed, no further promotional discount adjustments will be made to your registration.

Cancellation Policy

If you cancel your participation in this course, your registration fee, less a $25 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course ([email protected]).

Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.

If it has been more than 120 days since you paid for a course, or submitted a check for payment, a W9 form will need to be completed for us to refund your registration. You will not be taxed on your refund.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 6.75 Medical Knowledge MOC points. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MSK Course Director

Mario E. Lacouture, MD
Member, Memorial Hospital
Dermatology Service

MSK Course Co-Directors

Shari B. Goldfarb, MD
Assistant Attending
Breast Medicine Service

Robert Daly, MD, MBA
Attending
Lung Service

Invited Course Faculty

Anne R. Bass, MD
Rheumatology Fellowship Program Director
Hospital for Special Surgery
Professor of Clinical Medicine, 
Weill Cornell Medical College
New York, NY

Michael Dougan, MD, PhD
Assistant Professor, Medicine, Harvard Medical School
Assistant in Medicine, Medicine, Division of Gastroenterology,
Massachusetts General Hospital

Charles Loprinzi, MD
Consultant, Division of Medical Oncology
Department of Oncology
Mayo Clinic
Rochester, MN

MSK Course Faculty